Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1947 6
1948 1
1951 1
1952 2
1953 3
1954 2
1955 1
1956 2
1957 5
1958 3
1959 8
1960 2
1961 6
1962 3
1963 3
1964 6
1965 5
1966 6
1967 7
1968 4
1969 4
1970 14
1971 14
1972 5
1973 14
1974 13
1975 17
1976 16
1977 15
1978 28
1979 25
1980 29
1981 30
1982 40
1983 32
1984 37
1985 41
1986 47
1987 59
1988 82
1989 83
1990 86
1991 104
1992 101
1993 114
1994 94
1995 140
1996 151
1997 171
1998 167
1999 188
2000 244
2001 244
2002 258
2003 288
2004 287
2005 278
2006 322
2007 305
2008 338
2009 330
2010 385
2011 378
2012 408
2013 449
2014 584
2015 688
2016 683
2017 717
2018 726
2019 772
2020 883
2021 930
2022 851
2023 819
2024 322

Text availability

Article attribute

Article type

Publication date

Search Results

13,115 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for anti thoma
Search for Anthi Thoma instead (2 results)
Acute Amiodarone Pulmonary Toxicity.
Feduska ET, Thoma BN, Torjman MC, Goldhammer JE. Feduska ET, et al. J Cardiothorac Vasc Anesth. 2021 May;35(5):1485-1494. doi: 10.1053/j.jvca.2020.10.060. Epub 2020 Nov 5. J Cardiothorac Vasc Anesth. 2021. PMID: 33262034 Review.
A review of Dengvaxia®: development to deployment.
Thomas SJ, Yoon IK. Thomas SJ, et al. Hum Vaccin Immunother. 2019;15(10):2295-2314. doi: 10.1080/21645515.2019.1658503. Epub 2019 Oct 7. Hum Vaccin Immunother. 2019. PMID: 31589551 Free PMC article. Review.
Severe disease can manifest as plasma leakage and potential for clinically significant hemorrhage, shock, and death. Treatment is supportive and there is currently no licensed anti-dengue virus prophylactic or therapeutic compound. A single dengue vaccine, Sanofi Pasteur's …
Severe disease can manifest as plasma leakage and potential for clinically significant hemorrhage, shock, and death. Treatment is supportive …
Anti-racism in CanMEDS 2025.
Osei-Tutu K, Duchesne N, Barnabe C, Richardson L, Razack S, Thoma B, Maniate JM. Osei-Tutu K, et al. Can Med Educ J. 2023 Mar 21;14(1):33-40. doi: 10.36834/cmej.75844. eCollection 2023 Mar. Can Med Educ J. 2023. PMID: 36998489 Free PMC article. No abstract available.
Pharmacological treatment of acquired QT prolongation and torsades de pointes.
Thomas SH, Behr ER. Thomas SH, et al. Br J Clin Pharmacol. 2016 Mar;81(3):420-7. doi: 10.1111/bcp.12726. Epub 2015 Oct 26. Br J Clin Pharmacol. 2016. PMID: 26183037 Free PMC article. Review.
Other interventions are rarely needed, but there are case reports of successful use of lidocaine or phenytoin. Anti-arrhythmic drugs that prolong ventricular repolarization should be avoided. ...
Other interventions are rarely needed, but there are case reports of successful use of lidocaine or phenytoin. Anti-arrhythmic drugs …
Nuts: anti-atherogenic food?
Alexiadou K, Katsilambros N. Alexiadou K, et al. Eur J Intern Med. 2011 Apr;22(2):141-6. doi: 10.1016/j.ejim.2010.11.008. Epub 2010 Dec 31. Eur J Intern Med. 2011. PMID: 21402243 Review.
ACLF monocyte dysfunction.
Thoma C. Thoma C. Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):140-141. doi: 10.1038/s41575-019-0119-9. Nat Rev Gastroenterol Hepatol. 2019. PMID: 30723265 No abstract available.
Anti-TNF agents for rheumatoid arthritis.
Seymour HE, Worsley A, Smith JM, Thomas SH. Seymour HE, et al. Br J Clin Pharmacol. 2001 Mar;51(3):201-8. doi: 10.1046/j.1365-2125.2001.00321.x. Br J Clin Pharmacol. 2001. PMID: 11298065 Free PMC article. Review.
The disease is associated with significant morbidity and mortality with associated medical costs to the UK of between 240 m and 600 m per year. Non steroidal anti-inflammatory drugs (NSAIDs) have little effect on the underlying course of RA, but they have some anti- …
The disease is associated with significant morbidity and mortality with associated medical costs to the UK of between 240 m and 600 m per ye …
Cultivating diversity as an ethos with an anti-racism approach in the scientific enterprise.
Thomas SP, Amini K, Floyd KJ, Willard R, Wossenseged F, Keller M, Scott JB, Abdallah KE, Buscetta A, Bonham VL. Thomas SP, et al. HGG Adv. 2021 Sep 21;2(4):100052. doi: 10.1016/j.xhgg.2021.100052. eCollection 2021 Oct 14. HGG Adv. 2021. PMID: 35047843 Free PMC article. Review.
One way for this ethos to be sustained is by facilitating an intentional anti-racism approach within the field. Adopting a new perspective on diversity utilizing an anti-racism approach will support genomics researchers as we build supportive, collaborative research …
One way for this ethos to be sustained is by facilitating an intentional anti-racism approach within the field. Adopting a new perspe …
Do anti-tumour necrosis factor-alpha biologics affect subclinical measures of atherosclerosis and arteriosclerosis? A systematic review.
Knowles L, Nadeem N, Chowienczyk PJ. Knowles L, et al. Br J Clin Pharmacol. 2020 May;86(5):837-851. doi: 10.1111/bcp.14215. Epub 2020 Mar 8. Br J Clin Pharmacol. 2020. PMID: 31957052 Free PMC article. Review.
AIMS: Inflammatory cytokines, particularly tumour necrosis factor-alpha (TNFalpha), are thought to promote arterial disease through a variety of mechanisms leading to arteriosclerosis and atherosclerosis. We reviewed the existing evidence of the effect of anti-TNFalpha tre …
AIMS: Inflammatory cytokines, particularly tumour necrosis factor-alpha (TNFalpha), are thought to promote arterial disease through a variet …
Biologics for dengue prevention: up-to-date.
Waickman AT, Newell K, Endy TP, Thomas SJ. Waickman AT, et al. Expert Opin Biol Ther. 2023 Jan;23(1):73-87. doi: 10.1080/14712598.2022.2151837. Epub 2022 Dec 5. Expert Opin Biol Ther. 2023. PMID: 36417290 Review.
Sequential dengue virus (DENV) infections with different DENV types significantly increase the risk of severe disease. Treatment is supportive in nature as there are no licensed anti-DENV antivirals or immuno-therapeutics. A single dengue vaccine has widely been licensed w …
Sequential dengue virus (DENV) infections with different DENV types significantly increase the risk of severe disease. Treatment is supporti …
13,115 results
You have reached the last available page of results. Please see the User Guide for more information.